Literature DB >> 11576909

Two cases of non-O157:H7 Escherichia coli hemolytic uremic syndrome caused by urinary tract infection.

M C Hogan1, J M Gloor, J R Uhl, F R Cockerill, D S Milliner.   

Abstract

Escherichia coli serotype O157:H7 is a leading cause of diarrhea and hemolytic uremic syndrome (HUS). Because of the limitations of current diagnostic techniques, the prevalence of non-O157:H7 Shiga toxin-producing E coli strains is not known. We describe two patients with HUS in whom no E coli O157:H7 was demonstrable in stool cultures. On culture of the urine, the first patient was found to have E coli O113:H21 strain, and the second patient had E coli O6:H1 serotype. Shiga toxin production (stx2) by the O113:H21 isolate was confirmed. The first patient required 15 days of peritoneal dialysis and subsequently recovered renal function. At last follow-up, serum creatinine was 0.9 mg/dL. The second patient had preservation of renal function throughout the acute illness with serum creatinine of 0.5 mg/dL. The clinical presentation, bacteriology, course, and outcome as well as epidemiologic implications of the increasing number of patients with E coli urinary tract infections associated with HUS are discussed. These cases illustrate the need to investigate patients with nondiarrheal HUS for infection with Shiga toxin-producing E coli of the non-O157 strain variety.

Entities:  

Mesh:

Year:  2001        PMID: 11576909     DOI: 10.1053/ajkd.2001.27731

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  12 in total

1.  Characterization of urinary tract infection-associated Shiga toxin-producing Escherichia coli.

Authors:  Francisco Toval; Roswitha Schiller; Iris Meisen; Johannes Putze; Ivan U Kouzel; Wenlan Zhang; Helge Karch; Martina Bielaszewska; Michael Mormann; Johannes Müthing; Ulrich Dobrindt
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

2.  Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome.

Authors:  Gema Ariceta; Nesrin Besbas; Sally Johnson; Diana Karpman; Daniel Landau; Christoph Licht; Chantal Loirat; Carmine Pecoraro; C Mark Taylor; Nicole Van de Kar; Johan Vandewalle; Lothar B Zimmerhackl
Journal:  Pediatr Nephrol       Date:  2008-09-18       Impact factor: 3.714

3.  Invasion of epithelial cells by locus of enterocyte effacement-negative enterohemorrhagic Escherichia coli.

Authors:  Shelley N Luck; Vicki Bennett-Wood; Rachael Poon; Roy M Robins-Browne; Elizabeth L Hartland
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

4.  Contribution of FliC to epithelial cell invasion by enterohemorrhagic Escherichia coli O113:H21.

Authors:  Shelley N Luck; Luminita Badea; Vicki Bennett-Wood; Roy Robins-Browne; Elizabeth L Hartland
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

5.  Hemolytic-uremic syndrome after Escherichia coli urinary tract infection in humans: systematic review of the literature.

Authors:  Dejan Lavrek; Sebastiano A G Lava; Gregorio P Milani; Giacomo D Simonetti; Mario G Bianchetti; Olivier Giannini
Journal:  J Nephrol       Date:  2018-10-17       Impact factor: 3.902

6.  Analysis of urinary Escherichia coli isolates for ability to produce Shiga toxin.

Authors:  James R Johnson; Catherine Jerome; Daniel R Boster; Ann E Stapleton; Phillip I Tarr
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

7.  Differences in virulence among Escherichia coli O157:H7 strains isolated from humans during disease outbreaks and from healthy cattle.

Authors:  Diane R Baker; Rodney A Moxley; Mike B Steele; Jeffrey T Lejeune; Jane Christopher-Hennings; Ding-Geng Chen; Philip R Hardwidge; David H Francis
Journal:  Appl Environ Microbiol       Date:  2007-09-21       Impact factor: 4.792

8.  Hemolytic uremic syndrome (HUS)--incidence and etiologies at a regional Children's Hospital in 2001-2006.

Authors:  R J Pomajzl; M Varman; A Holst; A Chen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-08-16       Impact factor: 3.267

9.  Distinct pathotypes of O113 Escherichia coli strains isolated from humans and animals in Brazil.

Authors:  L F dos Santos; E M Gonçalves; T M I Vaz; K Irino; B E C Guth
Journal:  J Clin Microbiol       Date:  2007-04-19       Impact factor: 5.948

Review 10.  Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management.

Authors:  Benoit Travert; Cédric Rafat; Patricia Mariani; Aurélie Cointe; Antoine Dossier; Paul Coppo; Adrien Joseph
Journal:  Toxins (Basel)       Date:  2021-04-26       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.